The present invention relates generally to aerosol generators and, more particularly, to aerosol generators able to generate aerosols without compressed gas propellants and methods of making and using such aerosol generators. The present invention also relates generally to metering valves in inhalers and, more particularly, to metering valves which deliver a predetermined volume in inhalers including aerosol generators able to generate aerosols without compressed gas propellants.
Aerosols are useful in a wide variety of applications. For example, it is often desirable to treat respiratory ailments with, or deliver drugs by means of, aerosol sprays of finely divided particles of liquid and/or solid, e.g., powder, medicaments, etc., which are inhaled into a patient's lungs. Aerosols are also used for purposes such as providing desired scents to rooms, applying scents on the skin, and delivering paint and lubricant.
Various techniques are known for generating aerosols. For example, U.S. Pat. Nos. 4,811,731 and 4,627,432 both disclose devices for administering medicaments to patients in which a capsule is pierced by a pin to release a medicament in powder form. A user then inhales the released medicament through an opening in the device. While such devices may be acceptable for use in delivering medicaments in powder form, they are not suited to delivering medicaments in liquid form. The devices are also, of course, not well-suited to delivery of medicaments to persons who might have difficulty in generating a sufficient flow of air through the device to properly inhale the medicaments, such as asthma sufferers. The devices are also not suited for delivery of materials in applications other than medicament delivery.
Another well-known technique for generating an aerosol involves the use of a manually operated pump which draws liquid from a reservoir and forces it through a small nozzle opening to form a fine spray. A disadvantage of such aerosol generators, at least in medicament delivery applications, is the difficulty of properly synchronizing inhalation with pumping. More importantly, however, because such aerosol generators tend to produce particles of large size, their use as inhalers is compromised because large particles tend to not penetrate deep into the lungs.
One of the more popular techniques for generating an aerosol including liquid or powder particles involves the use of a compressed propellant, often containing a chloro-fluoro-carbon (CFC) or methylchloroform, to entrain a material, usually by the Venturi principle. For example, inhalers containing compressed propellants such as compressed gas for entraining a medicament are often operated by depressing a button to release a short charge of the compressed propellant. The propellant entrains the medicament as the propellant flows over a reservoir of the medicament so that the propellant and the medicament can be inhaled by the user. Since the medicament is propelled by the propellant, such propellant-based arrangements are well-suited for those who might have difficulty inhaling. Nonetheless, aerosols generated by propellant-based arrangements have particles that are too large to ensure deep lung penetration.
In propellant-based arrangements, however, a medicament may not be properly delivered to the patient's lungs when it is necessary for the user to time the depression of an actuator such as a button with inhalation. Moreover, such arrangements tend to be poorly suited for delivery of materials in large quantities. Although propellant-based aerosol generators have wide application for uses such as antiperspirant and deodorant sprays and spray paint, their use is often limited because of the well-known adverse environmental effects of CFC's and methylchloroform, which are among the most popular propellants used in aerosol generators of this type.
In drug delivery applications, it is typically desirable to provide an aerosol having average mass median particle diameters of less than 2 microns to facilitate deep lung penetration. Most known aerosol generators are incapable of generating aerosols having average mass median particle diameters less than 2 to 4 microns. It is also desirable, in certain drug delivery applications, to deliver medicaments at high flow rates, e.g., above 1 milligram per second. Most known aerosol generators suited for drug delivery are incapable of delivering such high flow rates in the 0.2 to 2.0 micron size range.
U.S. Pat. No. 5,743,251, which is hereby incorporated by reference in its entirety, discloses an aerosol generator, along with certain principles of operation and materials used in an aerosol generator, as well as a method of producing an aerosol, and an aerosol. The aerosol generator disclosed according to the '251 patent is a significant improvement over earlier aerosol generators, such as those used as inhaler devices. It is desirable to produce an aerosol generator that is portable and easy to use.
According to one aspect of the present invention, an aerosol generator includes a flow passage such as a tube having an inlet and an outlet, a heater arranged relative to the flow passage for heating at least a portion of the flow passage, a source of material to be volatilized, the inlet of the flow passage being in communication with the source of material, and a valve operatively located between the source of material and the flow passage, the valve being openable and closeable to open and close communication between the source and the outlet of the flow passage. A pressurization arrangement is provided for causing material in the source of material to be introduced into the flow passage from the source of material when the valve is in an open position. A source of power is provided for operating the heater and for the valve, and a control device is provided for controlling supply of power from the source of power to the heater and the valve.
According to a further aspect of the present invention, a method of making an aerosol generator is disclosed. According to the method, a heater is arranged relative to a flow passage for heating of the flow passage, the flow passage having an inlet and an outlet. The inlet of the flow passage is connected to a source of material to be volatilized. An openable and closeable valve is provided between the source of material and the flow passage. A pressurization arrangement is provided for causing material in the source of material to be introduced into the flow passage from the source of material when the valve is in an open position. The valve is connected to a source of power for opening and closing the valve. The heater is connected to the source of power. The source of power is connected to a control device for controlling a supply of power from the source of power to the heater and the valve.
According to yet another aspect of the present invention, a method of generating an aerosol is disclosed. According to the method, a first signal indicative of a user's intention to generate an aerosol, is generated and sent to a control device. With the control device and responsive to the first signal, a second signal is sent to a source of power to cause the source of power to open an openable and closeable valve, the valve being disposed between a source of material to be volatilized and a flow passage, opening of the valve permitting material from the source of material to flow from the source of material and into the flow passage. Material from the source of material is thus caused to flow from the source of material and into the flow passage. With the control device and responsive to the first signal, a third signal is sent to the source of power to supply power to a heater disposed relative to the flow passage to heat the flow passage. Material from the source of material is heated in the flow passage with the heater to a vaporization temperature such that the material volatilizes and expands out of an outlet of the flow passage.
The present invention also provides a metering device in an inhaler having a pressurized source of medicated fluid and a metering chamber in fluid communication with the pressurized source of fluid. The metering chamber is configured to deliver a predetermined volume of fluid to a heated flow passage in an inhaler.
In accordance with one embodiment of the metering device, the metering chamber is a rotary valve including a bore and a displacement member located within the bore. The displacement member is movable from a first position where the fluid is loaded into a load portion of the bore to a second position where the predetermined volume of fluid is ejected out of the bore.
In accordance with another embodiment of the metering device, the metering device includes a delivery passage including an elastic portion. The metering chamber is located in the elastic portion of the delivery passage. The elastic portion of the delivery passage is compressed to eject a predetermined volume of liquid.
In accordance with another aspect of the invention, the inhaler preferably includes an aerosol generator wherein a flow passage has an inlet and an outlet and a pressurized source of fluid, a heater is arranged relative to the flow passage for heating at least a portion of the flow passage; and a metering chamber is in fluid communication with the pressurized source of fluid and is configured to deliver a predetermined volume to the flow passage.
In accordance with another aspect of the invention, a method of dispensing a predetermined volume of medicated fluid in an inhaler is provided wherein the inhaler includes a metering device having a pressurized source of fluid which is in fluid communication with a metering chamber. According to the method, the metering chamber is filled with fluid from the pressurized source and a predetermined volume of the fluid is ejected from the metering chamber into a heated flow passage.
The features and advantages of the present invention are well understood by reading the following detailed description in conjunction with the drawings in which like numerals indicate similar elements and in which:
An aerosol generator 21 according to the present invention is shown in
A preferred application for the aerosol generator 21 is as an inhaler device, such as an inhaler for medicaments, such as asthma medication and pain killers or any other therapeutic agents for treatment of a bodily condition. The aerosol generator 21 preferably includes a first component 23, which preferably includes, for example, the material to be turned into an aerosol and which is preferably disposable after one or a predetermined plurality of uses, removably attached to a second component 25, which preferably includes, for example, power source and logic circuitry structures and which is preferably permanent in the sense that it is reusable with successive ones of the first components. The first and second components 23 and 25 can be, attachable to one another in end to end or side by side relationships. If desired or necessary, however, the aerosol generator can be a one-piece device.
The first component 23 preferably includes a flow passage in the form of a tube 27 having a first and a second end 29, 31, and a heater 33 arranged relative to the tube for heating the tube. A valve 35 is provided either on the tube 27 or between the second end 31 of the tube and a source 37 of material, the valve preferably being openable and closeable to open and close communication between the first end 29 of the tube and the source of material. The valve 35 may define the second end 31 of the tube. The valve 35 is preferably electronically openable and closeable, preferably a solenoid-type valve. The first component 23 preferably further includes the source 37 of material to be volatilized. The first component 23 preferably also includes a pressurization arrangement 39 for causing material in the source 37 of material to be introduced into the tube 27 from the source of material when the valve 35 is in an open position.
The second component 25 is preferably attachable and detachable to the first component 23 and includes a source 41 of power for the heater 33 and for the valve 35, and a control device 43, such as a microchip, for controlling supply of power from the source of power to the heater and the valve. The source 41 of power is preferably a battery, more preferably a rechargeable battery, however, the source of power may, if desired or necessary, be a non-depleting source of power, such as a conventional power line. International Publication No. WO 98/17131 discloses a power controller and a method of operating an electrical smoking system that discloses a power source and a control device, particularly for heaters, the principles of operation and features of which are transferrable to the present invention, and is hereby incorporated by reference.
In WO 98/17131 power is applied to a heater element in accordance with a predetermined series of phases with each phase assigned different target total energies per phase and predetermined time periods for each phase such that a heat treatment event is achieved. In WO 98/17131 the controller is configured to modulate power in each phase so that the target energies are maintained irrespective of externalities such as battery voltage or the like. Preferably all liquid entering the flow passage formed by the tube 27 is volatilized before being discharged from the tube 27. Power modulation within one or more phases of a power cycle as described above can optionally be used to assure that such volatilization occurs consistently over a broad range of battery voltages such as those encountered along a battery discharge cycle.
General operation of the aerosol generator 21 involves a user providing a signal, such as by compressing a button or performing some other action such as inhaling near the first end 29 of the tube 27 to actuate a flow sensing detector or a pressure drop sensing detector, which is received by the control device 43. In response to the signal, the control device 43 preferably controls the supply of power from the power source 41 such that the valve 35 is opened and power is supplied to the heater 33 to cause it to heat up to its desired operating temperature. It may be desired or necessary, depending upon the application and the equipment employed, to open the valve 35 before or after supplying power to the heater 33.
Upon opening the valve 35, the pressurization arrangement 39 causes material in the source 37 of material to be introduced into the tube 27. The material in the tube 27 is heated to a vaporization temperature in the tube, volatilizes, and expands out of the free first end 29 of the tube. Upon exiting the tube 27, the volatilized material contacts cooler air and condenses to form an aerosol. Preferably, after a predetermined period of time, the control device 43 automatically closes the valve 35 and shuts off the supply of power to the heater 33. After one or a plurality of uses, the first component 23 is preferably separated from the second component 25 and is disposed of, and a new first component is attached to the second component for further use.
Because presently preferred applications for the aerosol generator 21 include use as an inhaler, the aerosol generator is preferably as small as possible. The valve 35 is preferably a microvalve. More preferably, the valve 35, the heater 33, and the tube 27 are a single microelectronic machine formed on a single chip. To the extent that other components of the aerosol generator 21 disclosed in the present application are subject to production as microelectronic devices, they may also be formed on a single chip with the valve 35, the heater 33, and the tube 27, or on another chip.
According to the preferred embodiment, the source 37 of material includes a flexible container 45, and the pressurization arrangement 39 includes a chamber 47 in which the flexible container is disposed. A pressurized gas G is preferably sealed in the chamber 47 and surrounds the flexible container 45. The pressurization arrangement 39 is preferably a so-called sepra container of the type used for dispensing, for example, gel shaving creams, caulking compounds, and depilatories, although other pressurization arrangements for delivering the material, such as propellants and manual or automatic pumps, may be used if desired or necessary. The sepra container pressurization system is particularly preferred, however, particularly due to its capacity for resistance to surrounding temperature variations, as well as to variations in pressure of the gas G because the gas is not depleted. When it is desired to dispense material from the source 37 of material, and the valve 35 is opened, the pressure of the gas G, which is preferably about two atmospheres (about 30 psi) greater than ambient pressure, compresses the flexible container 45, causing material to enter the tube 27 through the second end 31 of the tube in communication with the source of material. A preferred gas G is nitrogen because of its ready availability and comparatively low cost, although various other gases are also suitable and may be preferred for particular applications.
Displacement of material from the flexible container 45 means that there is more room in the chamber 47, which means that the gas G enclosed in the chamber occupies a greater volume. Preferably, the size of the flexible container 45 relative to the size of the chamber 47 is selected such that pressure of the gas G is about ten percent lower when the flexible container is empty than when the flexible container is full.
A pressure sensor 48 may be provided to sense the pressure of the gas G in the chamber 47. As seen in
A signal to the control device 43 to supply power to the valve 35 and the heater 33 and, where provided, other features of the aerosol generator 21, is preferably provided by a user of the aerosol generator. While the signal may be provided by, for example, pressing a button, turning a knob, or switching a switch, a preferred arrangement for providing a signal is based on a user causing some manner of air flow in the proximity of the free first end 29 of the tube 27, such as by inhaling on a mouthpiece section 49 of the aerosol generator. The aerosol generator 21 preferably includes an air flow detecting device 51 for determining when a predetermined air flow rate exists proximate the first end 29 of the tube 27. The air flow detecting device 51 is preferably arranged to send a signal to the control device 43 to indicate that the predetermined air flow rate exists, which may be indicative that a user is drawing on the open end 53 of the mouthpiece 49 section, and the controller is preferably arranged to control the power source to supply power to the valve 35 and the heater 33, and any other components, in response to the signal from the air flow detecting device. As seen in
Where the aerosol generator 21 is a multi-piece device, the air flow detecting device 51 is preferably permanently attached to the second component 25 and is, thus, preferably a permanent component, i.e., it is not disposed of. If desired or necessary, however, the air flow detecting device 51 can be a disposable component forming part of the first component 23 and can be removably connected, such as through an electrical connection, to the control device 43.
The mouthpiece section 49 preferably has an open end 53. The tube 27 is preferably disposed in the mouthpiece section 49 and the first end 29 of the tube is preferably disposed inside of the mouthpiece section at a distance from the open end 53 to permit complete mixing of volatilized material expanding out of the first end of the tube with surrounding air to form an aerosol. To ensure an adequate supply of air for mixing with the volatilized material, as well as to ensure an adequate supply of air for permitting a user to draw on the mouthpiece section and actuate the air flow detecting device 51, the mouthpiece section 49 preferably has a plurality of vent holes 55. To facilitate the flow of air past the first end 29 of the tube 27 and thereby facilitate formation of an aerosol, the first end of the tube is preferably disposed in the mouthpiece section 49 between the vent holes 55 and the open end 53 of the mouthpiece section. The vent holes 55 are preferably located relative to the tube 27, preferably close to the end 29, such that air passing through the vent holes has no or minimal cooling effect on the tube. The tube 27 may, of course, be insulated from air flowing through the vent holes 55, such as by providing insulation material or a concentric tube 56 (shown in phantom) or the like around the tube to channel air away from the tube.
As an alternative to, or in addition to, using an air flow detecting device 51 to send a signal to the control device 43, as seen in
A suitable pressure drop detecting device is a puff-actuated sensor in the form of a Model 163PC01D35 silicon sensor, manufactured by MicroSwitch division of Honeywell, Inc., Freeport, Ill., or an SLP004D 0–4″ H2O Basic Sensor Element, manufactured by SenSym, Inc., Milpitas, Calif. Other known flow-sensing devices, such as those using hot-wire anemometry principles, are also believed to be suited for use with the aerosol generator 21. The use of an air flow detecting device 51, as compared to a pressure drop detecting device, is presently preferred for inhaler-type applications because it is anticipated that an air flow detecting device will be easier for users to actuate as compared to a pressure drop detecting device.
Presently anticipated applications for the aerosol generating device 21 include drug delivery applications. For such applications, as well as in other applications to which the aerosol generating device 21 might be applied, the control device 43 may include a timer 59 for controlling a frequency with which the control device controls the power supply 41 to supply power to the valve 35 and the heater 33 and other components. In this way, the aerosol generating device 21 can automatically limit the frequency with which a user can operate the aerosol generating device, thereby facilitating in preventing accidental misuse and overdosages. Moreover, to assist caregivers in treating their patients, the aerosol generator 21 can be associated with a remote control device 61 remote from the control device 43. The remote control device 61 is preferably capable of adjusting the timer 59 to adjust the frequency with which the control device 43 controls the power supply 41 to supply power to the valve 35 and the heater 33, and other components. In this way, when a caregiver desires to increase or decrease the frequency with which the user is able to operate the aerosol generator, the caregiver can do so in situations where the caregiver and the user are separated by some distance. In this way, users who might otherwise be required to personally see their caregivers to have their treatment schedules adjusted have greater mobility.
The control device 43 and, if provided, the remote control device 61, may also be configured to permit adjustment or remote adjustment of other powered components of the aerosol generator 21, such as the length of time that the valve 35 is open, and the length of time that power is supplied to the heater from the power source 41. In this manner, it is possible to adjust dosages up or down, as well as to adjust operating conditions of the aerosol generator 21 to maintain the same operation where, for example, pressure of the gas G in the chamber 47 drops or the rate at which power is supplied from the power source 41 reduces, such as where the aerosol generator is used in different temperatures, material in the flexible container 45 is used up, or the charge of a battery forming the power source diminishes.
The timer 59 of the control device preferably is associated with an indicator 63, such as a beeper or light forming part of the timer or, for example, electrically connected to the timer, for indicating that the control device 43 is available to control the power supply 41 to supply power to the valve 35 and the heater 33 and other components. Where, for example, the aerosol generator 21 is used to dispense medication, the indicator 63 serves to remind the user that it is time for the medication. The indicator 63 may also, if desired or necessary, be operable by the remote control device 61. The indicator 63 may also be used to indicate to a user a length of time since the aerosol generator 21 was actuated, such as where the aerosol generator is used as an inhaler, and the user is supposed to hold his or her breath for a length of time after inhaling, with the indicator 63 indicating when a period of time has elapsed.
The aerosol generator 21 may also include a display device 65, such as an LCD display, for displaying information such as a number of times that the control device 43 controls the power supply 41 to supply power to the valve and the heater. The display device 65 may display, for example, a number of times that the aerosol generator 21 has been operated, e.g., 1 or 2 or 3, or a number of operations remaining, which may be based on, for example, the size of the source 37 of material and the amount of material dispensed each time that the valve 35 is opened and closed, or the life of the power supply 41, such as the remaining life of a battery. The same or additional display devices can be provided to display other information, such as pressure in the pressure chamber 47 and power level of the power source 41. Further, the aerosol generator 21 may be equipped with various sensors and displays to provide feedback to be displayed in a display device 65 to, for example, assist a user in learning how to use the aerosol generator properly as an inhaler, such as sensors to measure the volume and duration of an inhalation after completion of an inhalation, and even to provide feedback during an inhalation to assist the user in employing an optimum inhalation profile. The display device 65 is preferably controlled by the control device 43 and powered by the power supply 41.
The control device 43 may be individually programmable, such as by a pharmacist, to control the aerosol generator 21 to dispense medications according to a prescription, i.e., quantity of medication, frequency, etc., as well as programming in the information that would prevent improper use of the aerosol generator. In this manner, fewer types of aerosol generators 21 may be useful for a wide range of medications. The particular aerosol generator 21 would preferably be optimized for different classes of medications and then “fine tuned” by, for example, the pharmacist, for a specific drug or prescription.
The aerosol generator 21 may also be programmed to permanently prevent use after a set period of time. In this way, it would be possible to prevent the use of expired medications. This may be accomplished by, for example, having a battery power source 41 be non-replaceable, or by incorporating a battery and/or control device that keeps track of date and time and prevents operation past a particular date and time.
While not wishing to be bound by theory, depending upon selection of factors presently understood to primarily include a rate of power supplied from the source of power 41 to the heater 33, a diameter of the tube 27, and the material to be volatilized and delivered as an aerosol, the aerosol generator 21 is preferably specifically designed to generate an aerosol having certain desired characteristics. For many applications, particularly for medication delivery applications, the aerosol generator 21 according to the present invention is preferably designed to produce an aerosol having a mass median particle diameter of less than 3 microns, more preferably less than 2 microns, still more preferably between 0.2 and 2 microns, and still more preferably between 0.5 and 1 microns. While not wishing to be bound by theory, depending upon selection of factors presently understood to primarily include a length of the tube 27, a pressure with which the pressurization arrangement 39 supplies the material from the source 37 of material, and a rate at which power is supplied from the source 41 of power, the rate at which the material is supplied and volatilized in the tube is established. The aerosol generator 21 is preferably designed to supply and volatilize material at a rate greater than 1 milligram per second.
It may be desirable to produce an aerosol formed from different liquid components that, for a variety of reasons, may be best kept separated until the moment that it is desired to form the aerosol. As seen in
The source 137 of second material preferably includes a second flexible container 145. The pressurization arrangement 39 preferably includes a second chamber 147 in which the second flexible container 145 is disposed, and a second pressurized gas G2 sealed in the second chamber and surrounding the second flexible container. The pressurized gas G and the second pressurized gas G2 may be pressurized to different pressures to facilitate delivery of the material and the second material to the tube 27 at different rates. If desired or necessary, the flexible container 45 and the second flexible container 145 may be disposed in the same pressurized chamber. Additional sources of material and other components may be provided to produce an aerosol having still further components.
As seen with respect to
The aerosol generator 221 preferably includes a chamber 249, such as a mouthpiece section. The first ends 29 and 229 of the tube 27 and the second tube 227 are preferably disposed in the chamber 249 proximate each other. The chamber 249 is preferably of sufficient size and configuration to permit mixture of volatilized material and volatilized second material that expands out of the tube 27 and the second tube 227 together with ambient air such that the volatilized material and the volatilized second material form first and second aerosols, respectively, the first and second aerosols being mixed with each other to form a combination aerosol including the first and second aerosols.
In the embodiment described with reference to
As noted, a preferred pressurization arrangement 39 for the aerosol generator 21 includes a sepra container type of arrangement. An aerosol generator 321 having an alternative pressurization arrangement 339 is shown in
As seen in
In a method of making the aerosol generator 21 described with reference to the embodiment shown in
The pressurization arrangement 39 for causing material in the source 37 of material to be introduced into the tube 27 from the source of material when the valve 35 is in an open position is provided. The valve 35 is connected to the source 41 of power for opening and closing the valve. The heater 35 is connected to the source 41 of power. The source 41 of power is connected to the control device 43 for controlling the supply of power from the source of power to the heater 33 and the valve 35, as well as to any other components of the aerosol generator.
The step of providing the pressurization arrangement 39 preferably includes positioning the source 37 of material in a chamber 47 and pressurizing the chamber, preferably to about two atmospheres. The source 37 of material preferably includes a flexible container 45. However, other embodiments are also possible. For example, as described with reference to FIGS. 5 and 6A–6B, the source 337 of material may include a second tube 345 having first and second ends 345a, 345b, the first end of the second tube being connected to the second end 31 of the tube 27 and the second end 345b of the second tube being positioned in the chamber 345.
In making the aerosol generator 21 according to the present invention, it is particularly preferred that the heater 33, the tube 27, the valve 35, the source 37 of material, and the pressurization arrangement 39 are arranged relative to each other to form a first component 23, and that the source 41 of power and the control device 43 are arranged relative to each other to form a second component 25, and that the second component is attachable to and detachable from the first component. In this way, the second component 25 can be made as a permanent device, with most or all of the more expensive features of the aerosol generator being associated with the second component, and the first component 23, which preferably includes the depletable or less expensive components of the aerosol generator, can be disposable. The different features of the aerosol generator 21 can be provided on whichever one of the components 23 and 25 seems appropriate for a particular application. However, according to the presently envisioned preferred application of the aerosol generator as a medical inhaler device, it is believed that the arrangement of features on the components 23 and 25 properly distributes the more and less disposable features.
The aerosol generator 21 is preferably used by a user providing a first signal, indicative of a user's intention to use the aerosol generator, to the control device 43. The first signal may be provided by the user pressing a button 58 (
The control device 43, in response to the first signal, sends a second signal to the source of power 41 to cause the source of power to open the openable and closeable valve 35. The valve 35 is preferably disposed between the tube 27 and the source 37 of material. Opening of the valve 35 permits material from the source 37 of material to flow from the source of material and into the tube 27.
Material from the source 37 of material is caused to flow from the source of material and into the tube 27, preferably by means of the pressurization arrangement. The source 37 of material preferably includes the flexible container 45, and material in container is caused to flow from the source of material by a pressurization arrangement 39. The pressurization arrangement 39 preferably includes the chamber 47 filled with gas G under pressure and in which the flexible container 45 is disposed. In an alternative embodiment, as described with reference to FIGS. 5 and 6A–6C, the source 337 of material includes the second tube 345 having first and second ends 345a, 345b. The first end 345a of the second tube 345 is connected to the second end 31 of the tube 27, and material in the source 337 of material is caused to flow from the source of material by the pressurization arrangement 339. The pressurization arrangement 339 includes a chamber 347 filled with gas G under pressure and in which the second end 345b of the second tube 345 is disposed.
A third signal is sent by the control device 43 and in response to the first signal to the source 41 of power to supply power to the heater 33 disposed relative to the tube 27 to heat the tube. Material from the source 37 of material is heated in the tube 27 with the heater 35 to a vaporization temperature such that the material volatilizes and expands out of the first end 29 of the tube.
The aerosol generator according to the present invention is preferably constructed in accordance with certain design principles that the inventors have recognized. These design relationships permit design of the aerosol generator with a certain robustness, particularly with respect to ambient temperature and container pressure variations, such that it is possible to ensure that the rate of aerosol delivery is substantially constant. While not wishing to be bound by theory, one relationship involves the rate at which aerosol is delivered (D), which is understood to be substantially linearly related to the pressure delivered to the liquid to be volatilized, i.e., the pressure (P), according to the relationship: D=k1P, where k1 is substantially constant and depends upon design factors peculiar to the particular aerosol generator.
The control device 43 can be programmed to ensure that as the pressure of the gas G drops certain changes in operation to accommodate these changes will take place. For example, as the pressure of the gas G drops, delivery of the same amount of material will take a longer time. Accordingly, the control device 43 can be programmed to, for example, keep the valve 35 open for a longer time. While not wishing to be bound by theory, in the case where the flow passage comprises a circular bore of capillary tube, for a given aerosol delivery rate D, tube diameter d could be chosen taking into account the effect of tube diameter upon particle size.
It is desirable that an inhaler deliver an accurately repeatable volume of medication to a user. In developing an inhaler which operates by volatilizing a fluid delivered to a heated flow passage such as a tube, it is desirable to deliver a repeatable and precise volume to the heated tube. Thus, a metering device for use in an inhaler according to the invention is preferably capable of reliably delivering a known volume of fluid to an aerosolizing portion of an inhaler (e.g., a heated tube).
According to one embodiment of the invention, an inhaler is provided wherein one or more parts contacted by medicated fluid are disposable after a particular number of delivered inhalation doses (e.g., 200). As such, it would be desirable for a metering device of such an inhaler to have a simple and cost-efficient design including a minimum number of wetted parts.
A metering device in accordance with a preferred embodiment of the present invention includes a pressurized source of medicated fluid and a metering chamber which provides precise and repeatable volumetric dispensing of the fluid. The metering device preferably includes a small number of wetted parts and is simple to manufacture.
For a better understanding of the invention, the following detailed description refers to the accompanying drawings, wherein exemplary embodiments of the present invention are illustrated and described.
An inhaler 401 including an exemplary metering device 403 is shown schematically in
In this example the metering chamber 407 in the rotary valve includes a bore 415 containing a sliding or “floating” piston 417. First and second openings 419, 421 at each end of the bore 415 can have diameters smaller than the diameter of the piston 417 so that the piston 417 is contained within the bore 415. However, the piston 417 can be maintained in the bore 415 by any suitable arrangement such as by providing suitably sized flow passages in housing 406 which contain the piston in the bore. A predetermined volume is defined as the difference between the volume of the bore 415 and the volume of the piston 417.
According to this arrangement the predetermined volume is delivered with each stroke of the piston 417. For example, pressurized fluid enters the first opening 419 in the rotary valve and moves the sliding piston 417 from a first position where the sliding piston 417 is adjacent the first opening 419 in the bore to a second position where the sliding piston 417 is adjacent to the second opening 421, thereby loading the predetermined volume of fluid into the rotary valve 405. When the rotary valve 405 is rotated to bring the second opening 421 of the bore into fluid communication with the pressurized source of fluid 408, the sliding piston 417 moves under pressure of the fluid from the first position to the second position to eject the predetermined volume out of the first opening 419 into a heated tube 409 and load a new predetermined volume through the second opening 421 in the rotary valve 405. Thus, in the example shown in
Preferably, to prevent fluid leakage, the piston 417 includes one or more sliding seals such as O-rings 425 which also separate a load side of the piston from an ejection side of the piston 417. Other means of sealing the load side of the piston 417 from the ejection side of the piston 417 are also within the scope of the invention. For example, the piston 417 can be designed in a manner and/or made of a material which provides one or more sections which matingly engage the bore to slidingly seal the ejection side of the load side.
The predetermined volume is determined by the difference between the volume of the sliding piston 417 and the volume of the bore 415. For example a 5 μl volume can be delivered by a piston having a 0.093 inch diameter and a stroke of 0.048 inches within the bore 415. The predetermined volume can be modified simply by changing a single dimension of the metering chamber 407. For example the predetermined volume can be increased by shortening the piston 417 or increasing the length of the bore 415, thereby increasing the stroke of the piston 417. Accordingly, the predetermined volume can be easily and inexpensively modified to accommodate children's inhalation doses and adult inhalation doses, as well as the varying delivered volumes required for a range of medications.
According to a modified embodiment, the piston can be replaced with a flexible diaphragm 427 secured within the bore 415. An example of a rotary valve of this sort is shown schematically in
It is desirable that the pressurized source of fluid 408 maintain a substantially constant pressure as fluid is depleted from the pressurized source 408. That is, it is preferred that there be an insignificant change in pressure of the fluid delivered by the source 408 between delivery of the first delivered volume and the last delivered volume. The source of fluid 408 can be pressurized in any suitable manner. For instance, as shown in
An example of a mechanism for actuating the rotary valve 405 is shown schematically in
The first gear 445 engages a second gear 451 which is on a shaft 452 connected to the rotary valve 405. As the shaft 452 is rotated, the bore 415 is rotated relative to the source of fluid 408. For example, the first gear 445 can include 60 teeth and the second gear 451 can include 20 teeth such that when the first gear is rotated 60° the second gear 451 rotates 180°.
It is desirable to time heating of the flow passage in a capillary aerosol type inhaler with the ejection of the predetermined volume of fluid so that the fluid is efficiently volatilized in the flow passage. An exemplary timing device includes a pair of contacts or cam surfaces 453 on the second gear 451 to provide exposed ends 455 spaced about 180° from one another. A spring-loaded electrical contact or switch 457 is connected to a heating mechanism (not shown) for the flow passage. The spring loaded electrical contact or switch 457 is triggered each time it makes contact with an end of the surface 457. Thus, according to this embodiment, each 180° rotation of the shaft 452 containing the rotary valve 405 ejects a predetermined volume, loads a predetermined volume and triggers the heating mechanism to heat the attached flow passage.
As mentioned in the embodiment described in
Another example of a metering device 463 according to the present invention is shown schematically in
The predetermined volume is determined by an inner diameter of the elastic tube 471 and the length of the tube 471 which is sealed off and emptied by the metering roller 475. As in the other examples illustrating the present invention, the predetermined volume can be varied by changing a single dimension of the metering device. For example, to increase the predetermined volume, an inner diameter of the elastic tube 471 or path of roller 475 can be increased.
An advantage of this example of a metering device 463 is that the fluid can be isolated in the elastic tube thus avoiding direct contact with moving parts. Also, in a reusable inhaler, the liquid source can be designed to be replaced with a cartridge having the delivery passage 465 attached thereto after a predescribed number of metered volumes have been delivered by a depleted liquid source.
Another example of a metering device 463 according to present invention is shown schematically in
In the example shown, a wheel 491 including five rollers 493 is located adjacent the elastic portion 487 of the delivery passage 485. Each roller 493 is separated from adjacent rollers by 72°. The wheel 491 is arranged adjacent the elastic portion 487 of the delivery passage 485 so that as the wheel 491 is rotated the convex surfaces of the rollers 493 deform the elastic sheet 489 into and against the convex surface of the delivery passage 485.
As shown in
The wheel 491 rotates on a shaft 495 which can be turned manually or with a mechanical, or electromechanical mechanism. For example, the shaft 495 can be turned by a conventional spring driven clock motor 497. According to this arrangement the flow rate of fluid ejected can be controlled in addition to the predetermined volume. The clock motor 497 controls the time period and rate at which the wheel 491 rotates the predetermined distance. In this way, the predetermined volume can be metered at a predetermined rate.
The components of the metering chamber according to the present invention can be manufactured using conventional injection molding techniques. The components can be molded out of plastic resins or other materials known to be appropriate for inhaler applications.
According to the present invention a metering device can be provided which delivers a repeatable, precise volume of a medicated fluid in an inhaler. In addition, the metering device according to the present invention has few wetted parts and is simple to manufacture. Accordingly, the metering device according to the present invention is well suited for use in inhalers and in particular heated capillary aerosol inhalers.
While this invention has been illustrated and described in accordance with a preferred embodiment, it is recognized that variations and changes may be made therein without departing from the invention as set forth in the claims. For instance, the aerosol generator could include arrangements for manually operating the valve 35, i.e., instead of actuation by detection of air flow or pressure drop, with the controller 43 being configured to execute a scheduled heating cycle upon receipt of a signal indicating actuation of the valve. Such arrangements might further include devices (electrical or mechanical) to maintain the valve 35 in an opened position for a predetermined amount of time once it is mechanically actuated. Further, the mouthpiece is optional and need not be incorporated in inhalers or other devices utilizing the aerosol generator according to the invention.
This application is a continuation of application Ser. No. 10/247,776, filed on Sep. 20, 2002 ABN, which is a continuation of application Ser. No. 0/479,597, filed on Jan. 7, 2000 now U.S. Pat. No. 6,516,796, which is a continuation of PCT/US99/24080, filed Oct. 14, 1999, which is a continuation of application Ser. No. 09/172,023, filed Oct. 14, 1998 now U.S. Pat. No. 6,234,167.
Number | Name | Date | Kind |
---|---|---|---|
2896856 | Kravits | Jul 1959 | A |
3084698 | Smith | Apr 1963 | A |
3157179 | Paullus et al. | Nov 1964 | A |
3162324 | Houser | Dec 1964 | A |
3431393 | Katsuda | Mar 1969 | A |
3486663 | Humphrey | Dec 1969 | A |
3658059 | Steil | Apr 1972 | A |
3716416 | Adlhart et al. | Feb 1973 | A |
3750961 | Franz | Aug 1973 | A |
3847304 | Cohen | Nov 1974 | A |
3859398 | Havstad | Jan 1975 | A |
3902635 | Jinotti | Sep 1975 | A |
3903883 | Pecina et al. | Sep 1975 | A |
3904083 | Little | Sep 1975 | A |
3967001 | Almaula et al. | Jun 1976 | A |
3987941 | Blessing | Oct 1976 | A |
3993246 | Erb et al. | Nov 1976 | A |
3995371 | O'Keefe | Dec 1976 | A |
4042153 | Callahan et al. | Aug 1977 | A |
4060082 | Lindberg et al. | Nov 1977 | A |
4077542 | Petterson | Mar 1978 | A |
4161282 | Erb et al. | Jul 1979 | A |
4162501 | Mitchell et al. | Jul 1979 | A |
4215708 | Bron | Aug 1980 | A |
4231492 | Rios | Nov 1980 | A |
4258073 | Payne | Mar 1981 | A |
4259409 | Arnold | Mar 1981 | A |
4261356 | Turner et al. | Apr 1981 | A |
4289003 | Yang | Sep 1981 | A |
4291838 | Williams | Sep 1981 | A |
4303083 | Burruss, Jr. | Dec 1981 | A |
4383171 | Sinha et al. | May 1983 | A |
4391308 | Steiner | Jul 1983 | A |
4395303 | Weir | Jul 1983 | A |
4433797 | Galia | Feb 1984 | A |
4471892 | Coleman | Sep 1984 | A |
4512341 | Lester | Apr 1985 | A |
4575609 | Fassel et al. | Mar 1986 | A |
4627432 | Newell et al. | Dec 1986 | A |
4649911 | Knight et al. | Mar 1987 | A |
4682010 | Drapeau et al. | Jul 1987 | A |
4695625 | Macdonald | Sep 1987 | A |
4700657 | Butland | Oct 1987 | A |
4730111 | Vestal et al. | Mar 1988 | A |
4735217 | Gerth et al. | Apr 1988 | A |
4744932 | Browne | May 1988 | A |
4749778 | Fukuzawa et al. | Jun 1988 | A |
4762995 | Browner et al. | Aug 1988 | A |
4776515 | Michalchik | Oct 1988 | A |
4790305 | Zoltan et al. | Dec 1988 | A |
4811731 | Newell et al. | Mar 1989 | A |
4819374 | Gemgnani | Apr 1989 | A |
4819834 | Thiel | Apr 1989 | A |
4829996 | Noakes et al. | May 1989 | A |
4837260 | Sato et al. | Jun 1989 | A |
4848374 | Chard et al. | Jul 1989 | A |
4871115 | Hessey | Oct 1989 | A |
4871623 | Hoopman et al. | Oct 1989 | A |
4877989 | Drews et al. | Oct 1989 | A |
4911157 | Miller | Mar 1990 | A |
4922901 | Brooks et al. | May 1990 | A |
4926852 | Zoltan et al. | May 1990 | A |
4935624 | Henion et al. | Jun 1990 | A |
4941483 | Ridings et al. | Jul 1990 | A |
4947875 | Brooks et al. | Aug 1990 | A |
4974754 | Wirz | Dec 1990 | A |
4982097 | Slivon et al. | Jan 1991 | A |
4992206 | Waldron | Feb 1991 | A |
5021802 | Allred | Jun 1991 | A |
5044565 | Alexander | Sep 1991 | A |
5056511 | Ronge | Oct 1991 | A |
5060671 | Counts et al. | Oct 1991 | A |
5063921 | Howe | Nov 1991 | A |
5096092 | Devine | Mar 1992 | A |
5125441 | Mette | Jun 1992 | A |
5133343 | Johnson et al. | Jul 1992 | A |
5134993 | van der Linden et al. | Aug 1992 | A |
5135009 | Müller et al. | Aug 1992 | A |
5144962 | Counts et al. | Sep 1992 | A |
5151827 | Ven et al. | Sep 1992 | A |
5178305 | Keller | Jan 1993 | A |
5184776 | Minier | Feb 1993 | A |
5217004 | Blasnik et al. | Jun 1993 | A |
5226441 | Dunmire et al. | Jul 1993 | A |
5228444 | Burch | Jul 1993 | A |
5230445 | Rusnak | Jul 1993 | A |
5231983 | Matson et al. | Aug 1993 | A |
5259370 | Howe | Nov 1993 | A |
5284133 | Burns et al. | Feb 1994 | A |
5290540 | Prince et al. | Mar 1994 | A |
5298744 | Mimura et al. | Mar 1994 | A |
5299565 | Brown | Apr 1994 | A |
5322057 | Raabe et al. | Jun 1994 | A |
5327915 | Porenski et al. | Jul 1994 | A |
5342180 | Daoud | Aug 1994 | A |
5342645 | Eisele et al. | Aug 1994 | A |
5349946 | McComb | Sep 1994 | A |
5395445 | Bohanan | Mar 1995 | A |
5421489 | Holzner, Sr. et al. | Jun 1995 | A |
5462597 | Jubran | Oct 1995 | A |
5474059 | Cooper | Dec 1995 | A |
5487378 | Robertson et al. | Jan 1996 | A |
5509557 | Jimarez et al. | Apr 1996 | A |
5515842 | Ramseyer et al. | May 1996 | A |
5522385 | Lloyd et al. | Jun 1996 | A |
5556964 | Hofstraat et al. | Sep 1996 | A |
5564442 | MacDonald et al. | Oct 1996 | A |
5565677 | Wexler | Oct 1996 | A |
5575929 | Yu et al. | Nov 1996 | A |
5585045 | Heinonen et al. | Dec 1996 | A |
5617844 | King | Apr 1997 | A |
5642728 | Andersson et al. | Jul 1997 | A |
5674860 | Carling et al. | Oct 1997 | A |
5682874 | Grabenkort et al. | Nov 1997 | A |
5730158 | Collins et al. | Mar 1998 | A |
5743251 | Howell et al. | Apr 1998 | A |
5755218 | Johansson et al. | May 1998 | A |
5756995 | Maswadeh et al. | May 1998 | A |
5765724 | Amberg et al. | Jun 1998 | A |
5813397 | Goodman et al. | Sep 1998 | A |
5823178 | Lloyd et al. | Oct 1998 | A |
5839430 | Cama | Nov 1998 | A |
5855202 | Andrade | Jan 1999 | A |
5856671 | Henion et al. | Jan 1999 | A |
5863652 | Matsumura et al. | Jan 1999 | A |
5869133 | Anthony et al. | Feb 1999 | A |
5872010 | Karger et al. | Feb 1999 | A |
5878752 | Adams et al. | Mar 1999 | A |
5881714 | Yokoi et al. | Mar 1999 | A |
5906202 | Schuster et al. | May 1999 | A |
5914122 | Otterbeck et al. | Jun 1999 | A |
5932249 | Gruber et al. | Aug 1999 | A |
5932315 | Lum et al. | Aug 1999 | A |
5934272 | Lloyd et al. | Aug 1999 | A |
5934273 | Andersson et al. | Aug 1999 | A |
5944025 | Cook et al. | Aug 1999 | A |
5954979 | Counts et al. | Sep 1999 | A |
5957124 | Lloyd et al. | Sep 1999 | A |
5970973 | Gonda et al. | Oct 1999 | A |
5970974 | Van Der Linden et al. | Oct 1999 | A |
5978548 | Holmstrand et al. | Nov 1999 | A |
5993633 | Smith et al. | Nov 1999 | A |
6014970 | Ivri et al. | Jan 2000 | A |
6053176 | Adams et al. | Apr 2000 | A |
6054032 | Haddad et al. | Apr 2000 | A |
6069214 | McCormick et al. | May 2000 | A |
6069219 | McCormick et al. | May 2000 | A |
6070575 | Gonda et al. | Jun 2000 | A |
6071428 | Franks et al. | Jun 2000 | A |
6071554 | Isomura et al. | Jun 2000 | A |
6076522 | Dwivedi et al. | Jun 2000 | A |
6077543 | Gordon et al. | Jun 2000 | A |
6080721 | Patton | Jun 2000 | A |
6085740 | Ivri et al. | Jul 2000 | A |
6085753 | Gonda et al. | Jul 2000 | A |
6089228 | Smith et al. | Jul 2000 | A |
6095153 | Kessler et al. | Aug 2000 | A |
6098615 | Lloyd et al. | Aug 2000 | A |
6098620 | Lloyd et al. | Aug 2000 | A |
6103270 | Johnson et al. | Aug 2000 | A |
6116516 | Ga{overscore (n)}án-Calvo | Sep 2000 | A |
6116893 | Peach | Sep 2000 | A |
6119953 | Ga{overscore (n)}án-Calvo | Sep 2000 | A |
6123068 | Lloyd et al. | Sep 2000 | A |
6123936 | Platz et al. | Sep 2000 | A |
6131567 | Gonda et al. | Oct 2000 | A |
6131570 | Schuster et al. | Oct 2000 | A |
6136346 | Eljamal et al. | Oct 2000 | A |
6138668 | Patton et al. | Oct 2000 | A |
6155268 | Takeuchi | Dec 2000 | A |
6158431 | Poole | Dec 2000 | A |
6158676 | Hughes | Dec 2000 | A |
6159188 | Laibovitz et al. | Dec 2000 | A |
6164630 | Birdsell et al. | Dec 2000 | A |
6165463 | Platz et al. | Dec 2000 | A |
6167880 | Gonda et al. | Jan 2001 | B1 |
6174469 | Ga{overscore (n)}án-Calvo | Jan 2001 | B1 |
6182712 | Stout et al. | Feb 2001 | B1 |
6187214 | Ga{overscore (n)}án-Calvo | Feb 2001 | B1 |
6187344 | Eljamal et al. | Feb 2001 | B1 |
6189803 | Ga{overscore (n)}án-Calvo | Feb 2001 | B1 |
6192882 | Gonda | Feb 2001 | B1 |
6197835 | Ga{overscore (n)}án-Calvo | Mar 2001 | B1 |
6205999 | Ivri et al. | Mar 2001 | B1 |
6206242 | Amberg et al. | Mar 2001 | B1 |
6207135 | Rössling et al. | Mar 2001 | B1 |
6223746 | Jewett et al. | May 2001 | B1 |
6230706 | Gonda et al. | May 2001 | B1 |
6231851 | Platz et al. | May 2001 | B1 |
6234167 | Cox et al. | May 2001 | B1 |
6234402 | Ga{overscore (n)}án-Calvo | May 2001 | B1 |
6235177 | Borland et al. | May 2001 | B1 |
6250298 | Gonda et al. | Jun 2001 | B1 |
6257233 | Burr et al. | Jul 2001 | B1 |
6258341 | Foster et al. | Jul 2001 | B1 |
6263872 | Schuster et al. | Jul 2001 | B1 |
6267155 | Parks et al. | Jul 2001 | B1 |
6275650 | Lambert | Aug 2001 | B1 |
6276347 | Hunt | Aug 2001 | B1 |
6284525 | Mathies et al. | Sep 2001 | B1 |
6288360 | Beste | Sep 2001 | B1 |
6290685 | Insley et al. | Sep 2001 | B1 |
6294204 | Rössling et al. | Sep 2001 | B1 |
6295986 | Patel et al. | Oct 2001 | B1 |
6318361 | Sosiak | Nov 2001 | B1 |
6491233 | Nichols | Dec 2002 | B1 |
6501052 | Cox et al. | Dec 2002 | B1 |
6516796 | Cox et al. | Feb 2003 | B1 |
6557552 | Cox et al. | May 2003 | B1 |
6766220 | McRae et al. | Jul 2004 | B1 |
6772757 | Sprinkel, Jr. | Aug 2004 | B1 |
6923179 | Gupta et al. | Aug 2005 | B1 |
20010032647 | Schuster et al. | Oct 2001 | A1 |
Number | Date | Country |
---|---|---|
354004 | Sep 1928 | BE |
354094 | Sep 1928 | BE |
1036470 | Apr 1958 | DE |
358114 | Mar 1990 | EP |
642802 | Mar 1995 | EP |
667979 | Oct 1929 | FR |
168128 | Feb 1976 | HU |
168128 | Apr 1993 | HU |
207457 | Apr 1993 | HU |
P 95034-0 | Jun 1994 | HU |
216121 | Apr 1999 | HU |
WO 9409842 | May 1994 | WO |
WO 9749441 | Dec 1997 | WO |
9817131 | Apr 1998 | WO |
WO 9817131 | Apr 1998 | WO |
Number | Date | Country | |
---|---|---|---|
20040050383 A1 | Mar 2004 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10247776 | Sep 2002 | US |
Child | 10438329 | US | |
Parent | 09479597 | Jan 2000 | US |
Child | 10247776 | US | |
Parent | PCT/US99/24080 | US | |
Child | 09479597 | US | |
Parent | 09172023 | Oct 1998 | US |
Child | PCT/US99/24080 | US |